다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Cogent Biosciences Inc (COGT)
Cogent Biosciences Inc (COGT) 뉴스

COGT

Cogent Biosciences (COGT)

Cogent Biosciences Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:COGT

1 2 3 4 5 6 7 8 9 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/12/10	06:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:COGT	Cogent Biosciences Inc
2024/12/09	21:00	GlobeNewswire Inc.	Cogent Biosciences Announces Updated Clinical Results from SUMMIT, Showcasing Powerful Symptomatic Improvement in NonAdvanced Systemic Mastocytosis Patients	NASDAQ:COGT	Cogent Biosciences Inc
2024/12/09	02:00	GlobeNewswire Inc.	Cogent Biosciences Announces Positive Updated Data from Ongoing Phase 2 APEX Trial Evaluating Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)	NASDAQ:COGT	Cogent Biosciences Inc
2024/11/15	06:05	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:COGT	Cogent Biosciences Inc
2024/11/15	02:24	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:COGT	Cogent Biosciences Inc
2024/11/12	22:00	GlobeNewswire Inc.	Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2024 Financial Results	NASDAQ:COGT	Cogent Biosciences Inc
2024/11/05	23:00	GlobeNewswire Inc.	Cogent Biosciences Announces Bezuclastinib Presentations at the 66th Annual American Society of Hematology (ASH) Meeting	NASDAQ:COGT	Cogent Biosciences Inc
2024/10/23	20:00	GlobeNewswire Inc.	Cogent Biosciences Announces Pipeline Expansion into KRAS and Poster Presentations at the 2024 EORTC-NCI-AACR International Symposium on Molecular Targets and Cancer Therapeutics	NASDAQ:COGT	Cogent Biosciences Inc
2024/09/03	21:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:COGT	Cogent Biosciences Inc
2024/09/03	21:00	GlobeNewswire Inc.	Cogent Biosciences Announces Phase 3 PEAK Trial in Patients with Gastrointestinal Stromal Tumors (GIST) Has Completed Enrollment and Advanced Past Interim Futility Analysis	NASDAQ:COGT	Cogent Biosciences Inc
2024/08/07	05:53	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:COGT	Cogent Biosciences Inc
2024/08/06	21:40	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:COGT	Cogent Biosciences Inc
2024/08/06	21:20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:COGT	Cogent Biosciences Inc
2024/08/06	21:00	GlobeNewswire Inc.	Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2024 Financial Results	NASDAQ:COGT	Cogent Biosciences Inc
2024/06/27	21:00	GlobeNewswire Inc.	Cogent Biosciences Announces Positive FDA Meeting and Alignment on MS2D2, a Novel Patient Reported Outcome Measure for the SUMMIT trial	NASDAQ:COGT	Cogent Biosciences Inc
2024/06/14	20:30	GlobeNewswire Inc.	Cogent Biosciences Announces Additional Clinical Data from Part 1 of its Ongoing SUMMIT Trial Evaluating Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM)	NASDAQ:COGT	Cogent Biosciences Inc
2024/06/14	08:18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:COGT	Cogent Biosciences Inc
2024/06/14	08:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:COGT	Cogent Biosciences Inc
2024/06/14	08:11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:COGT	Cogent Biosciences Inc
2024/06/14	08:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:COGT	Cogent Biosciences Inc
2024/06/13	19:06	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:COGT	Cogent Biosciences Inc
2024/06/13	10:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:COGT	Cogent Biosciences Inc
2024/06/06	05:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:COGT	Cogent Biosciences Inc
2024/05/30	05:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:COGT	Cogent Biosciences Inc
2024/05/30	05:01	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:COGT	Cogent Biosciences Inc
2024/05/24	06:05	GlobeNewswire Inc.	Cogent Biosciences Appoints Cole Pinnow as Chief Commercial Officer	NASDAQ:COGT	Cogent Biosciences Inc
2024/05/24	06:01	GlobeNewswire Inc.	Cogent Biosciences Announces Positive Updated Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluating Bezuclastinib in Combination with Sunitinib in Patients with Gastrointestinal Stromal Tumors (GIST) at ASCO Annual Meeting	NASDAQ:COGT	Cogent Biosciences Inc
2024/05/07	21:26	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:COGT	Cogent Biosciences Inc
2024/05/07	21:19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:COGT	Cogent Biosciences Inc
2024/05/07	21:00	GlobeNewswire Inc.	Cogent Biosciences Reports First Quarter 2024 Financial Results	NASDAQ:COGT	Cogent Biosciences Inc

검색 관련기사 보기:NASDAQ:COGT

1 2 3 4 5 6 7 8 9 다음 >>

JP Morgan Chase

BNP Paribas (QX)

Gold vs US Dollar

Health Care Select Sector

Bank of America

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관